FDA Launches Patient-Focused Drug Development Initiative

Clinical Trials Advisor
Acting on a mandate of the most recent user fee framework, the FDA has selected more than a dozen disease areas it plans to address as part of an initiative on patient-centered research through 2015.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00